Evidence map›Paper›PMID 31417182›Full record

ArticleOncogene2019

Inducible formation of leader cells driven by CD44 switching gives rise to collective invasion and metastases in luminal breast carcinomas.

Cuixia Yang, Manlin Cao, Yiwen Liu, Yiqing He, Yan Du, Guoliang Zhang, Feng Gao

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. The PROM1Cancer communications (London, England) · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Leader Cells: Invade and Evade-The Frontline of Cancer Progression.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. M1 macrophages induce PD-L1Journal for immunotherapy of cancer · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Cuixia Yang *Department of Molecular Biology Laboratory, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 200233, Shanghai, China.
Manlin Cao *Department of Rehabilitation Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 200233, Shanghai, China.
Yiwen LiuDepartment of Molecular Biology Laboratory, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 200233, Shanghai, China.
Yiqing HeDepartment of Molecular Biology Laboratory, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 200233, Shanghai, China.
Yan DuDepartment of Molecular Biology Laboratory, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 200233, Shanghai, China.
Guoliang ZhangDepartment of Molecular Biology Laboratory, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 200233, Shanghai, China.
Feng GaoDepartment of Molecular Biology Laboratory, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 200233, Shanghai, China. gao3507@126.com.
Shanghai Sixth People's Hospital · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Collective invasion into adjacent tissue is a hallmark of luminal breast cancer, and ~20% of these cases eventually undergo metastasis. How less aggressive luminal-like breast cancer transitions to invasive cancer remains unclear. Our study revealed that CD44

Indexed as

AnimalsBreast NeoplasmsCarcinomaCell MovementFemaleHumansHyaluronan ReceptorsMiceNeoplasm InvasivenessHyaluronan Receptors

Identifiers

PMID31417182
OpenAlexW2967246360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.